<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychol Med</journal-id><journal-id journal-id-type="iso-abbrev">Psychol Med</journal-id><journal-id journal-id-type="publisher-id">PSM</journal-id><journal-title-group><journal-title>Psychological Medicine</journal-title></journal-title-group><issn pub-type="ppub">0033-2917</issn><issn pub-type="epub">1469-8978</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40313134</article-id><article-id pub-id-type="pmc">PMC12094627</article-id>
<article-id pub-id-type="doi">10.1017/S003329172500100X</article-id><article-id pub-id-type="pii">S003329172500100X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Familial coaggregation and shared familiality of functional and internalizing disorders in the Lifelines cohort</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5288-2223</contrib-id><name><surname>Bos</surname><given-names>Martje</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1744-5447</contrib-id><name><surname>Monden</surname><given-names>Rei</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7421-3357</contrib-id><name><surname>Wray</surname><given-names>Naomi R.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yiling</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8689-6570</contrib-id><name><surname>Kendler</surname><given-names>Kenneth S.</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6393-0032</contrib-id><name><surname>Rosmalen</surname><given-names>Judith G. M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9282-8053</contrib-id><name><surname>van Loo</surname><given-names>Hanna M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1949-2298</contrib-id><name><surname>Snieder</surname><given-names>Harold</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Department of Psychiatry, <institution>University of Groningen, University Medical Center Groningen</institution>, <city>Groningen</city>, <country>The Netherlands</country>
</aff><aff id="aff2">
<label>2</label>Informatics and Data Science Program, Graduate School of Advanced Science and Engineering, <institution>Hiroshima University</institution>, <city>Hiroshima</city>, <country>Japan</country>
</aff><aff id="aff3">
<label>3</label>Institute for Molecular Bioscience, <institution>The University of Queensland</institution>, <city>Brisbane</city>, <state>QLD</state>, <country>Australia</country>
</aff><aff id="aff4">
<label>4</label>Department of Psychiatry and Big Data Institute, <institution>University of Oxford</institution>, <city>Oxford</city>, <country>UK</country>
</aff><aff id="aff5">
<label>5</label>Department of Epidemiology, <institution>University of Groningen, University Medical Center Groningen</institution>, <city>Groningen</city>, <country>The Netherlands</country>
</aff><aff id="aff6">
<label>6</label>Virginia Institute for Psychiatric and Behavioral Genetics, <institution>Virginia Commonwealth University</institution>, <city>Richmond</city>, <state>VA</state>, <country>USA</country>
</aff><aff id="aff7">
<label>7</label>Department of Psychiatry, <institution>Virginia Commonwealth University</institution>, <city>Richmond</city>, <state>VA</state>, <country>USA</country>
</aff><aff id="aff8">
<label>8</label>Department of Internal Medicine, <institution>University of Groningen, University Medical Center Groningen</institution>, <city>Groningen</city>, <country>The Netherlands</country>
</aff><author-notes><corresp id="cor1">
<bold>Corresponding author:</bold> M. Bos; Email: <email>m.bos03@umcg.nl</email>
</corresp><fn id="fn01" fn-type="other"><p>Judith G. M. Rosmalen, Hanna M. van Loo and Harold Snieder supervised this work.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2025"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>5</month><year>2025</year></pub-date><volume>55</volume><elocation-id>e126</elocation-id><history><date date-type="received"><day>26</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>12</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S003329172500100Xa.pdf"/><abstract><sec id="sec28"><title>Background</title><p>Functional disorders (FDs) are characterized by persistent somatic symptoms and are highly comorbid with internalizing disorders (IDs). To provide much-needed insight into FD etiology, we evaluated FD and ID familial coaggregation and shared familiality.</p></sec><sec id="sec29"><title>Methods</title><p>Lifelines is a three-generation cohort study, which assessed three FDs (myalgic encephalomyelitis/chronic fatigue syndrome [ME/CFS], irritable bowel syndrome [IBS], and fibromyalgia [FM]) and six IDs (major depressive disorder [MDD], dysthymia [DYS], generalized anxiety disorder [GAD], agoraphobia [AGPH], social phobia [SPH], and panic disorder [PD]) according to diagnostic criteria. Based on 153,803 individuals, including 90,397 with a first-degree relative in Lifelines, we calculated recurrence risk ratios (&#x003bb;<sub>R</sub>s) and tetrachoric correlations to evaluate familial aggregation and coaggregation of these disorders in first-degree relatives. We then estimated their familiality and familial correlations.</p></sec><sec id="sec30"><title>Results</title><p>Familial aggregation was observed across disorders, with &#x003bb;<sub>R</sub> ranging from 1.45 to 2.23 within disorders and from 1.17 to 1.94 across disorders. Familiality estimates ranged from 22% (95% confidence interval [CI]: 16&#x02013;29) for IBS to 42% (95% CI: 33&#x02013;50) for ME/CFS. Familial correlations ranged from +0.37 (95% CI: 0.24&#x02013;0.51) between FM and AGPH to +0.97 (95% CI: 0.80&#x02013;1) between ME/CFS and FM. The highest familial correlation between an ID and FD was +0.83 (95% CI: 0.66&#x02013;0.99) for MDD and ME/CFS.</p></sec><sec id="sec31"><title>Conclusions</title><p>There is a clear familial component to FDs, which is partially shared with IDs. This suggests that IDs and FDs share both genetic and family-environmental risk factors. Of the FDs, ME/CFS is most closely related to IDs.</p></sec></abstract><kwd-group><title>Key words</title><kwd>familial transmission</kwd><kwd>functional somatic syndromes</kwd><kwd>genetic correlations</kwd><kwd>heritability</kwd><kwd>mood and anxiety disorders</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><ref-count count="74"/><page-count count="10"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Functional disorders (FDs) are characterized by persistent somatic symptoms of unknown origin. In the absence of reproducibly observable pathophysiological processes, these disorders are diagnosed solely by symptoms. FDs are common (Haller, Cramer, Lauche, &#x00026; Dobos, <xref rid="r25" ref-type="bibr">2015</xref>; Nimnuan, Hotopf, &#x00026; Wessely, <xref rid="r46" ref-type="bibr">2001</xref>), costly (Konnopka et al., <xref rid="r38" ref-type="bibr">2012</xref>) and disabling (Joustra, Janssens, B&#x000fc;ltmann, &#x00026; Rosmalen, <xref rid="r30" ref-type="bibr">2015</xref>). The three best-known FDs are myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), irritable bowel syndrome (IBS), and fibromyalgia (FM), with estimated prevalences of 1.5%, 9.1%, and 1.8%, respectively (Heidari, Afshari, &#x00026; Moosazadeh, <xref rid="r27" ref-type="bibr">2017</xref>; Lim et al., <xref rid="r40" ref-type="bibr">2020</xref>; Rometsch et al., <xref rid="r52" ref-type="bibr">2024</xref>). Understanding of FD etiology is still limited, but both biological and psychosocial factors have been associated with these disorders (Kleinst&#x000e4;uber et al., <xref rid="r37" ref-type="bibr">2023</xref>).</p><p>There is evidence for a genetic component to FDs, with twin and genetic studies finding moderate levels of heritability for ME/CFS (Buchwald et al., <xref rid="r11" ref-type="bibr">2001</xref>), IBS (Svedberg, Johansson, Wallander, &#x00026; Pedersen, <xref rid="r61" ref-type="bibr">2008</xref>), and FM (Dutta et al., <xref rid="r20" ref-type="bibr">2020</xref>; Magnusson, Turkiewicz, Ryd&#x000e9;n, &#x00026; Englund, <xref rid="r41" ref-type="bibr">2024</xref>). Moreover, a family study observed heritable overlap between these FDs (Allen-Brady, Fyer, &#x00026; Weissman, <xref rid="r3" ref-type="bibr">2023</xref>). To increase understanding of FD etiology, further clarification of the genetic liability to FDs is important. However, genome-wide association studies (GWASs) of FDs are still in the early stages and have limited power (Bonfiglio et al., <xref rid="r9" ref-type="bibr">2018</xref>; Hajdarevic et al., <xref rid="r24" ref-type="bibr">2022</xref>; Moscati et al., <xref rid="r44" ref-type="bibr">2023</xref>). Studying genetic liability shared with related disorders can provide further insight into the genetics of FDs.</p><p>Due to their high comorbidity with FDs, internalizing disorders (IDs) are good candidates to study alongside FDs. For instance, individuals who meet diagnostic criteria for ME/CFS, IBS, or FM show higher rates of major depressive disorder (MDD) (odds ratios [ORs]&#x000a0;=&#x000a0;3.87&#x02013;12.62) and generalized anxiety disorder (GAD) (ORs&#x000a0;=&#x000a0;3.19&#x02013;9.81) than those who do not meet FD diagnostic criteria (Thomas et al., <xref rid="r66" ref-type="bibr">2024</xref>). Furthermore, a twin study suggests that FD-ID comorbidity is partly due to shared genetic factors (Kato, Sullivan, Eveng&#x000e5;rd, &#x00026; Pedersen, <xref rid="r31" ref-type="bibr">2009</xref>). Similarly, a study using Swedish registry data found that individuals diagnosed with ME/CFS, IBS, or FM have an increased familial genetic risk for IDs (Kendler et al., <xref rid="r36" ref-type="bibr">2023</xref>). Moreover, genetic loci associated with IBS have also been associated with depression and anxiety (Eijsbouts et al., <xref rid="r21" ref-type="bibr">2021</xref>; Tavares et al., <xref rid="r64" ref-type="bibr">2024</xref>; Tesfaye et al., <xref rid="r65" ref-type="bibr">2023</xref>). Thus, studying both the genetics and the genetic relationships of IDs and FDs may advance the understanding of the etiology of both types of disorders.</p><p>Family studies provide a useful approach to study the vulnerability shared between disorders. Two such studies explored familial coaggregation of multiple FDs and IDs, both finding coaggregation between FM and MDD (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>; Hudson et al., <xref rid="r29" ref-type="bibr">2004</xref>). One study also observed coaggregation across ME/CFS, IBS, FM, and panic disorder (PD) (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>). However, these studies either used medical records to define cases (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>) or recruited patients from medical centers (Hudson et al., <xref rid="r29" ref-type="bibr">2004</xref>). Both methods risk oversampling severe cases and may be influenced by help-seeking behavior and diagnostic biases (Tattan et al., <xref rid="r63" ref-type="bibr">2024</xref>). The current study aims to assess familial aggregation, coaggregation, familiality, and familial correlations of IDs and FDs. Familial aggregation and coaggregation examine whether diseases cluster together in families. Familiality, a concept closely related to heritability, is the proportion of phenotypic variation attributable to familial effects, that is genetic and shared environmental effects combined. Familial correlation is a measure of how much familial effects on one trait overlap with familial effects on another trait. This study is performed in the large population-based Lifelines cohort (N&#x000a0;=&#x000a0;153,803), which assessed FDs and IDs according to official diagnostic criteria.</p></sec><sec sec-type="methods" id="sec2"><title>Methods</title><sec sec-type="other" id="sec3"><title>Data</title><p>This study was conducted within the Lifelines cohort study. Lifelines is a multidisciplinary, prospective, population-based cohort study examining in a unique three-generation design the health and health-related behaviors of 167,729 persons living in the North of the Netherlands. It employs a broad range of investigative procedures to assess biomedical, sociodemographic, behavioral, physical, and psychological factors that contribute to health and disease in the general population, with a special focus on multimorbidity and complex genetics. Since 2006, three assessment waves have been completed (Sijtsma et al., <xref rid="r57" ref-type="bibr">2022</xref>) in 2006&#x02013;2013 (wave 1), 2014&#x02013;2017 (wave 2), and 2019&#x02013;2023 (wave 3). The current study used complete data from waves 1 and 2 as well as all data released from wave 3 up to 1 March 2024. The 153,803 adult participants with measurements on IDs or FDs during any of the three assessment waves were included in this study (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Figure&#x000a0;1</uri>).</p><p>The Lifelines cohort study followed the guidelines of the Declaration of Helsinki, and all procedures involving human subjects were approved by the Medical Ethical Committee of the University Medical Center Groningen. Furthermore, written informed consent was obtained from all participants.</p></sec><sec sec-type="other" id="sec4"><title>Measurements</title><sec sec-type="other" id="sec5"><title>Internalizing disorders</title><p>In all three waves, current MDD, dysthymia (DYS), GAD, agoraphobia (AGPH), social phobia (SPH), and PD were evaluated using the Mini-International Neuropsychiatric Interview (MINI) (Sheehan et al., <xref rid="r56" ref-type="bibr">1998</xref>), which assesses these disorders per DSM-IV criteria (American Psychiatric Association, <xref rid="r4" ref-type="bibr">1998</xref>). In wave 1, the MINI was administered as a face-to-face interview by a trained research nurse at a Lifelines research facility. In wave 2, participants completed a digital MINI questionnaire at the facility. In wave 3 used a digital MINI questionnaire emailed to participants for completion at home. The presence of MDD, DYS, and GAD required symptoms in the past two weeks, two years, and six months, respectively. The presence of AGPH, SPH, and PD required symptoms in the past month (van Loo et al., <xref rid="r68" ref-type="bibr">2023</xref>), conforming to DSM-IV-TR duration criteria (American Psychiatric Association, <xref rid="r5" ref-type="bibr">2000</xref>). Participants meeting the diagnostic criteria during any wave were labeled as cases; those who never met the criteria were labeled as controls. Thus, diagnostic status was determined based on assessments at up to three specific time points and does not include lifetime diagnoses.</p></sec><sec sec-type="other" id="sec6"><title>Functional disorders</title><p>ME/CFS disease status was assessed according to the 1994 Centers for Disease Control and Prevention (CDC) diagnostic criteria (Fukuda et al., <xref rid="r23" ref-type="bibr">1994</xref>). IBS status was assessed using ROME III criteria (Drossman, <xref rid="r18" ref-type="bibr">2006</xref>), but the criteria related to symptom occurrence were adjusted to align with ROME IV criteria (Drossman, <xref rid="r19" ref-type="bibr">2016</xref>). Thus, IBS was present if abdominal discomfort occurred more than once weekly, rather than three days a month, for over six months, in addition to two additional symptoms. FM was assessed according to the 2010 American College of Rheumatology (ACR) criteria (Wolfe et al., <xref rid="r72" ref-type="bibr">2010</xref>). FDs were only assessed in Lifelines&#x02019; second and third waves. Participants meeting the diagnostic criteria during any wave were labeled as cases; those who did not were labeled as controls. Thus, diagnostic status was determined based on assessments at up to two specific time points and does not include lifetime diagnoses.</p></sec></sec><sec sec-type="other" id="sec7"><title>Statistical analyses</title><sec sec-type="other" id="sec8"><title>Familial aggregation and coaggregation</title><p>Recurrence risk ratios (&#x003bb;<sub>R</sub>s) were calculated to assess familial aggregation and coaggregation (Risch, <xref rid="r51" ref-type="bibr">1990</xref>). &#x003bb;<sub>R</sub> is the ratio of disease prevalence in relatives of affected participants to the prevalence in the general population, that is the Lifelines population. We estimated these prevalences using plug-in methods from the &#x0201c;marginaleffects&#x0201d; package in R (Arel-Bundock, Greifer, &#x00026; Heiss, <xref rid="r80" ref-type="bibr">2024</xref>). First, we fitted a logistic regression model in which disease status (case or control) was regressed on whether a person had an affected relative while adjusting for age, age<sup>2</sup>, sex, and number of relatives in the data. This model quantified how these factors are associated with disease risk. Second, we estimated disease prevalences by plugging-in the fitted model to our study population: once with their existing covariate values to estimate prevalence in the general population, and once with each participant&#x02019;s relative affected status set to &#x02018;true&#x02019; (while keeping existing values for age, sex, and family size) to estimate prevalence among those with affected relatives. The ratio of these two prevalence estimates gives the marginal &#x003bb;<sub>R</sub>, which represents how much having an affected relative increases disease risk, averaged across the total population&#x02019;s distribution of age, sex, and family size. See <uri xlink:href="http://doi.org/10.1017/S003329172500100X">supplementary&#x000a0;methods</uri> for details. To ensure that we capture the full complexity of familial relationships without artificially separating comorbid cases, individuals with multiple diagnoses were included in the analysis for each of their conditions. To minimize reporting bias, proband reports of relatives&#x02019; disease status were not used (Milne et al., <xref rid="r43" ref-type="bibr">2009</xref>; Saito et al., <xref rid="r55" ref-type="bibr">2008</xref>). To account for correlated observations due to familial clustering, 95% confidence intervals (CIs) were estimated using a robust clustered sandwich method (Zeileis, K&#x000f6;ll, &#x00026; Graham, <xref rid="r75" ref-type="bibr">2020</xref>). In addition to calculating the &#x003bb;<sub>R</sub> for first-degree relatives in general, &#x003bb;<sub>R</sub> was also calculated for siblings, parents, and offspring separately and for second-degree relatives. Furthermore, &#x003bb;<sub>R</sub> was calculated for cohabiting spouses as a measure of spousal resemblance, which can arise as the result of assortative mating and/or shared environmental influences.</p><p>Unlike &#x003bb;<sub>R</sub>, tetrachoric correlations are relatively insensitive to differences in the prevalence of the disorders involved in the calculations (Babchishin &#x00026; Helmus, <xref rid="r7" ref-type="bibr">2016</xref>; Cummings, <xref rid="r15" ref-type="bibr">2009</xref>). Therefore, tetrachoric correlations were calculated for all parent-offspring pairs/trios and sibling pairs within families as an additional measures of familial aggregation and coaggregation. These correlations accounted for nonindependence within nuclear families within MPlus (Muth&#x000e9;n &#x00026; Muth&#x000e9;n, <xref rid="r45" ref-type="bibr">1998</xref>).</p></sec><sec sec-type="other" id="sec9"><title>Familiality and familial correlation</title><p>The terms heritability and genetic correlation imply that familial resemblance is solely due to genetics. Unlike twin studies, our family study did not disentangle genetic from shared environmental influences because an estimation of shared environment based on, for example, a comparison of first- and second-degree relatives would have limited power. To address this conflation and the resulting incomparability to heritability estimates from twin studies, we use the terms familiality and familial correlation instead of heritability and genetic correlation (Kendler &#x00026; Neale, <xref rid="r35" ref-type="bibr">2009</xref>).</p><p>To estimate the familiality of and familial correlations between FDs and IDs, we used the methods of Falconer (<xref rid="r22" ref-type="bibr">1965</xref>) and Reich, James, and Morris (<xref rid="r50" ref-type="bibr">1972</xref>), as adapted by Wray and Gottesman (<xref rid="r74" ref-type="bibr">2012</xref>) (Baselmans, Yengo, van Rheenen, &#x00026; Wray, <xref rid="r8" ref-type="bibr">2021</xref>). These methods are based on the liability threshold model, which assumes that a normally distributed liability underlies disease status. Individuals exceeding the critical liability threshold are affected. Although unobservable, this threshold can be determined using normal distribution theory, given the proportion of affected individuals in the population. The prevalence of disease in the general population and in thefirst- and second-degree relatives of affected individuals was used to estimate both the familiality of the disorders and the familial correlations between disorders. See <uri xlink:href="http://doi.org/10.1017/S003329172500100X">supplementary&#x000a0;methods</uri> for details.</p></sec><sec sec-type="other" id="sec10"><title>Sensitivity analyses</title><p>We performed three sensitivity analyses. First, given the functional limitations associated with IDs and FDs (Buist-Bouwman et al., <xref rid="r12" ref-type="bibr">2006</xref>; Joustra et al., <xref rid="r30" ref-type="bibr">2015</xref>), we hypothesized a higher dropout rate between assessment waves for individuals with affected relatives. This selective dropout could lead to underestimating disease prevalence in relatives of affected individuals, consequently resulting in an underestimation of &#x003bb;<sub>R</sub> and familiality. We used logistic regression to compare participation in the second and third waves between participants with and without affected first-degree relatives in wave 1 or 2, adjusting for age, sex, and the number of participating relatives in wave 2. For IDs, the participant&#x02019;s disease status in wave 1 was also considered, which was not possible for FDs as they were not assessed in wave 1. For wave 3, we additionally evaluated if individuals with affected relatives in any of the three waves were less likely to participate. Models were adjusted for age, sex, number of participating relatives in wave 3, and the individual&#x02019;s disease status in previous waves.</p><p>Second, to ensure specificity to FDs, participants who met the diagnostic criteria for an FD and reported a medical condition with similar symptoms were excluded from the familial coaggregation analyses. For ME/CFS, participants with multiple sclerosis (MS), dementia, schizophrenia, or an eating disorder were excluded. For IBS, participants with ulcerative colitis, Crohn&#x02019;s disease, or coeliac disease were excluded. For FM, participants with rheumatoid arthritis were excluded. Additionally, hepatitis, cancer, or heart failure were exclusion criteria for all FDs.</p><p>Third, we assessed the impact of differences in diagnostic criteria strictness for FDs. The diagnostic criteria for ME/CFS are stricter than those for IBS and FM; ME/CFS requires interference with daily tasks, while IBS and FM do not. Moreover, ME/CFS and IBS require a six-month duration, in contrast to three months for FM. Familial coaggregation is often stronger for more severe phenotypes (Steinhausen, Jakobsen, &#x00026; Munk-J&#x000f8;rgensen, <xref rid="r58" ref-type="bibr">2017</xref>; Wang, Snieder, &#x00026; Hartman, <xref rid="r70" ref-type="bibr">2022</xref>). Therefore, the duration and interference criteria of FM and IBS were aligned with ME/CFS criteria, meaning that a symptom duration of six months and interference with daily life activities were required for all three FDs. This helped assess to which extent differences between FDs in &#x003bb;<sub>R</sub> and tetrachoric correlations were due to (arbitrary) diagnostic criteria or due to a difference in the type of symptoms.</p></sec><sec sec-type="other" id="sec11"><title>Reporting and software</title><p>Results are considered significant if p&#x000a0;&#x0003c;&#x000a0;.01. Mplus version 8.2 (Muth&#x000e9;n &#x00026; Muth&#x000e9;n, <xref rid="r45" ref-type="bibr">1998</xref>) was used to calculate tetrachoric correlations. R Version 4.2.1 (R Core Team, <xref rid="r49" ref-type="bibr">2022</xref>) was used for all other analyses. R scripts are available at Open Science Framework (OSF), via doi: <uri xlink:href="https://doi.org/10.17605/OSF.IO/7RCVT">10.17605/OSF.IO/7RCVT</uri></p></sec></sec></sec><sec sec-type="results" id="sec12"><title>Results</title><sec sec-type="other" id="sec13"><title>Descriptives</title><p>The diagnostic status for IDs or FDs could be determined for 153,803 Lifelines participants, based on up to three assessments between 2006 and 2023 for IDs and up to two assessments between 2014 and 2023 for FDs. The descriptive characteristics of these individuals are presented in <xref rid="tab1" ref-type="table">Table 1</xref>. For 90,397 (58.8%) individuals, it was possible to determine disease status for at least one first-degree relative. The disease status of a second-degree relative could be assessed for 23,978 (15.6%) individuals. The data included 37,184 sibling pairs from 23,185 nuclear families, 16,455 parent-offspring pairs (a child with only one parent) from 11,916 nuclear families, and 17,046 parent-offspring trios (a child with both parents) from 11,357 nuclear families.<table-wrap position="float" id="tab1"><label>Table 1.</label><caption><p>Descriptive characteristics of dataset</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1" valign="bottom"/><th align="center" valign="bottom" rowspan="1" colspan="1">N (total dataset/subjects with first-degree relative in dataset)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total(N&#x000a0;=&#x000a0;153,803)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Participants with first-degree relatives in data<break/>(N&#x000a0;=&#x000a0;90,397)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Demographics</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Age<xref rid="tab1fn1" ref-type="table-fn"><sup>a</sup></xref>, mean (SD)</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">44.2 (13.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">44.4 (14.9)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Sex (Female), %</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">58.6</td><td align="center" valign="middle" rowspan="1" colspan="1">60.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Parent in &#x000a0;&#x000a0;&#x000a0;dataset, %</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">21.8</td><td align="center" valign="middle" rowspan="1" colspan="1">37.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Sibling in &#x000a0;&#x000a0;&#x000a0;data, %</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">34.1</td><td align="center" valign="middle" rowspan="1" colspan="1">58.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Child in data, %</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">22.4</td><td align="center" valign="middle" rowspan="1" colspan="1">38.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Spouse<xref rid="tab1fn2" ref-type="table-fn"><sup>b</sup></xref> in &#x000a0;&#x000a0;&#x000a0;data, %</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">38.9</td><td align="center" valign="middle" rowspan="1" colspan="1">41.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="2">Internalizing disorders<xref rid="tab1fn3" ref-type="table-fn"><sup>c</sup></xref>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;MDD, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">152,633/89,614</td><td align="center" valign="middle" rowspan="1" colspan="1">4.8</td><td align="center" valign="middle" rowspan="1" colspan="1">4.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;DYS<xref rid="tab1fn4" ref-type="table-fn"><sup>d</sup></xref>, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">150,462/88,543</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" rowspan="1" colspan="1">2.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;GAD, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">152,629/89,614</td><td align="center" valign="middle" rowspan="1" colspan="1">9.1</td><td align="center" valign="middle" rowspan="1" colspan="1">8.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;AGPH, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">152,629/89,615</td><td align="center" valign="middle" rowspan="1" colspan="1">5.8</td><td align="center" valign="middle" rowspan="1" colspan="1">5.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;SPH, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">152,626/89,614</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;PD, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">152,627/89,614</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="2">Functional disorders<xref rid="tab1fn5" ref-type="table-fn"><sup>e</sup></xref>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;ME/CFS, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">102,648/63,185</td><td align="center" valign="middle" rowspan="1" colspan="1">4.7</td><td align="center" valign="middle" rowspan="1" colspan="1">4.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;IBS, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">102,847/63,285</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;FM<xref rid="tab1fn6" ref-type="table-fn"><sup>f</sup></xref>, %</td><td align="char" char="/" valign="middle" rowspan="1" colspan="1">97,378/59,983</td><td align="center" valign="middle" rowspan="1" colspan="1">8.2</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7</td></tr></tbody></table><graphic xlink:href="S003329172500100X_tab1" position="float"/></alternatives><table-wrap-foot><p>Abbreviations: SD, standard deviation; MDD, major depressive disorder; DYS, dysthymia; GAD, generalized anxiety disorder; AGPH, agoraphobia; SPH, social phobia; PD, panic disorder; ME/CFS, myalgic encephalomyelitis/chronic fatigue syndrome; IBS, irritable bowel syndrome; FM, fibromyalgia.</p><fn id="tab1fn1" fn-type="other"><label>a</label><p>Age during the first adult assessment an individual participated in.</p></fn><fn id="tab1fn2" fn-type="other"><label>b</label><p>Pairs were considered spouses if they lived together during the baseline assessment and indicated to be spouses or share a child together. This includes same-sex spouses.</p></fn><fn id="tab1fn3" fn-type="other"><label>c</label><p>Cases aggregated across assessment waves 1, 2, and 3. Lifetime diagnoses were not established.</p></fn><fn id="tab1fn4" fn-type="other"><label>d</label><p>Sample size of DYS is smaller than for other IDs as in some assessment waves DYS questions were skipped if MDD was present.</p></fn><fn id="tab1fn5" fn-type="other"><label>e</label><p>Cases aggregated across assessment waves 2 and 3. Functional disorders were not assessed in first assessment wave. Lifetime diagnoses were not established.</p></fn><fn id="tab1fn6" fn-type="other"><label>f</label><p>Sample size of FM is smaller than for other FDs as FM questions were spread across two questionnaires.</p></fn></table-wrap-foot></table-wrap></p></sec><sec sec-type="other" id="sec14"><title>Familial aggregation and coaggregation</title><p>For all disorders except PD and DYS, having a first-degree relative affected by the disorder was significantly associated with a higher risk for all of the other disorders (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Estimates of &#x003bb;<sub>R</sub> ranged from 1.17 (95% CI: 1.06&#x02013;1.27) for IBS with a relative affected by AGPH to 2.23 for both PD and ME/CFS with a relative affected by the same disorder (95% CI: 1.26&#x02013;3.20 for PD, 1.89&#x02013;2.58 for ME/CFS). Familial coaggregation within IDs was similar to that within FDs. Among FDs, ME/CFS showed the strongest coaggregation with IDs, while IBS showed the weakest. Generally, familial coaggregation did not exhibit different patterns by type of first-degree relative (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;1</uri>).<fig position="float" id="fig1"><label>Figure 1.</label><caption><p>Familial coaggregation of internalizing and functional disorders amongst first-degree relatives expressed in &#x003bb;<sub>R</sub>. <italic toggle="yes">Note:</italic> FDR, first-degree relative; MDD, major depressive disorder; DYS, dysthymia; GAD, generalized anxiety disorder; AGPH, agoraphobia; SPH, social phobia; PD, panic disorder; ME/CFS, myalgic encephalomyelitis/chronic fatigue syndrome; IBS, irritable bowel syndrome; FM, fibromyalgia; &#x003bb;<sub>R</sub>, recurrence risk ratios. &#x003bb;<sub>R</sub> adjusted for age, age<sup>2</sup>, sex, and number of relatives present in the data. Estimates in bold are significant at p&#x000a0;&#x0003c;&#x000a0;.01. For 95% confidence intervals, see Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;1</uri>.</p></caption><graphic xlink:href="S003329172500100X_fig1" position="float"/></fig></p><p>Unlike the &#x003bb;<sub>R</sub> estimates for all first-degree relatives combined, tetrachoric correlations calculated between sibling pairs and between parent-offspring pairs/trios did not consistently reach statistical significance (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Patterns of familial coaggregation expressed in tetrachoric correlations did align with &#x003bb;<sub>R</sub> of sibling and parents-offspring pairs (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Tables&#x000a0;1</uri>&#x02013;<uri xlink:href="http://doi.org/10.1017/S003329172500100X">3</uri>). For instance, IBS was less strongly associated with IDs than ME/CFS and FM.<fig position="float" id="fig2"><label>Figure 2.</label><caption><p>Tetrachoric correlations between internalizing and functional disorders, for (a) siblings and (b) parent-offspring pairs/trios. <italic toggle="yes">Note:</italic> MDD, major depressive disorder; DYS, dysthymia; GAD, generalized anxiety disorder; AGPH, agoraphobia; SPH, social phobia; PD, panic disorder; ME/CFS, myalgic encephalomyelitis/chronic fatigue syndrome; IBS, irritable bowel syndrome; FM, fibromyalgia; r<sub>tet</sub>, tetrachoric correlation. Estimates in bold are significant at p&#x000a0;&#x0003c;&#x000a0;.01. For 95% confidence intervals, see Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Tables&#x000a0;2</uri> &#x00026; <uri xlink:href="http://doi.org/10.1017/S003329172500100X">3</uri>.</p></caption><graphic xlink:href="S003329172500100X_fig2" position="float"/></fig></p><p>Within disorders, significant spousal resemblance was observed for MDD, DYS, GAD, AGPH, ME/CFS, and FM. Furthermore, all disorders showed spousal coaggregation with at least one other disorder (<xref rid="fig3" ref-type="fig">Figure 3</xref>). In some cases, &#x003bb;<sub>R</sub> for spouses was larger than &#x003bb;<sub>R</sub> for first-degree relatives. For instance, for MDD &#x003bb;<sub>R</sub> for first-degree relatives was 1.76 (95% CI: 1.54&#x02013;1.98) while &#x003bb;<sub>R</sub> for spouses was 2.10 (95% CI: 1.63&#x02013;2.56).<fig position="float" id="fig3"><label>Figure 3.</label><caption><p>Familial coaggregation of internalizing and functional disorders amongst spouses, expressed in &#x003bb;<sub>R</sub>. <italic toggle="yes">Note:</italic> MDD, major depressive disorder; DYS, dysthymia; GAD, generalized anxiety disorder; AGPH, agoraphobia; SPH, social phobia; PD, panic disorder; ME/CFS, myalgic encephalomyelitis/chronic fatigue syndrome; IBS, irritable bowel syndrome; FM, fibromyalgia; &#x003bb;<sub>R</sub>, recurrence risk ratio. &#x003bb;<sub>R</sub> adjusted for age, age<sup>2</sup>, sex, and presence of spouse in the data. Estimates in bold are significant at p&#x000a0;&#x0003c;&#x000a0;.01. For 95% confidence intervals, see Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;1</uri>.</p></caption><graphic xlink:href="S003329172500100X_fig3" position="float"/></fig></p></sec><sec sec-type="other" id="sec15"><title>Familiality and familial correlation</title><p>In general, familiality estimates were modest to moderate, ranging from 22% (95% CI: 16&#x02013;29) for IBS to 42% (95% CI: 33&#x02013;50) for ME/CFS (<xref rid="fig4" ref-type="fig">Figure 4a</xref>). Familiality estimates based on second-degree relatives were similar to those based on first-degree relatives, except for SPH and ME/CFS (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;4</uri>). This suggests limited influences from shared environment for most disorders as second-degree relatives typically share much less of their family and community environment than do first-degree relatives. Moderate to high familial correlations were observed across disorders, ranging from +0.37 (95% CI: 0.24&#x02013;0.51) between AGPH and FM to +0.97 (95% CI 0.80&#x02013;1) between ME/CFS and FM. The familial correlation between MDD and ME/CFS was +0.83 (95% CI: 0.66&#x02013;0.99), which was the strongest familial correlation observed between an ID and FD (<xref rid="fig4" ref-type="fig">Figure 4b</xref>).<fig position="float" id="fig4"><label>Figure 4</label><caption><p>(a) Familiality and (b) familial correlation estimates of internalizing and functional disorders based on both first- and second-degree relatives. <italic toggle="yes">Note:</italic> MDD, major depressive disorder; DYS, dysthymia; GAD, generalized anxiety disorder; AGPH, agoraphobia; SPH, social phobia; PD, panic disorder; ME/CFS, myalgic encephalomyelitis/chronic fatigue syndrome; IBS, irritable bowel syndrome; FM, fibromyalgia; r<sub>f</sub>, familial correlation. See Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;4</uri> for familiality estimates for first- and second-degree relatives separately and Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;5</uri> for 95% confidence intervals of familial correlation estimates.</p></caption><graphic xlink:href="S003329172500100X_fig4" position="float"/></fig></p></sec><sec sec-type="other" id="sec16"><title>Sensitivity analysis</title><p>We assessed whether dropout between waves was higher among participants whose first-degree relative was affected by any of the disorders, as this could lead to an underestimation of disease prevalence in relatives of affected individuals. Individuals with a first-degree relative affected by MDD, GAD, AGPH, PD, or FM during the first or second assessment waves were less likely to participate in the MINI of wave 2. Those with a first-degree relative affected by PD were least likely to participate (OR: 0.86, 95% CI: 0.77&#x02013;0.97). Individuals with a first-degree relative affected by GAD in wave 1 or 2 were also less likely to participate in the FD questionnaire of wave 2 (OR: 0.90, 95% CI: 0.86&#x02013;0.94). For wave 3, individuals with a first-degree relative affected by MDD, GAD, AGPH, CFS, or FM in any of the assessment waves were less likely to participate in both the MINI and the FD questionnaire. Individuals whose first-degree relative was affected by FM were least likely to participate in the wave 3 MINI (OR: 0.86, 95% CI: 0.81&#x02013;0.91) and the FD questionnaire (OR: 0.87, 95% CI: 0.81&#x02013;0.92). See Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;6</uri> for all logistic regression results.</p><p>To ensure specificity to FDs, subjects with somatic disorders were excluded from familial aggregation and coaggregation analyses, reducing the prevalence of ME/CFS, IBS, and FM to 3.9%, 6.3%, and 6.6%, respectively. This exclusion had no to a minimal impact on familial coaggregation estimates (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Tables&#x000a0;7</uri>&#x02013;<uri xlink:href="http://doi.org/10.1017/S003329172500100X">9</uri>).</p><p>To account for differences in strictness of diagnostic criteria, IBS and FM duration and interference criteria were aligned with ME/CFS to include 6-6-month duration and interference with daily activities. This reduced IBS prevalence from 7.5% to 1.1% and FM prevalence from 8.2% to 4.5%. Severity-aligned IBS coaggregated more with IDs than the original criteria. Although ME/CFS still showed stronger coaggregation with IDs than severity-aligned FM, differences did attenuate, indicating that criteria strictness partly explains the familial aggregation differences (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Tables&#x000a0;10</uri>&#x02013;<uri xlink:href="http://doi.org/10.1017/S003329172500100X">12</uri>).</p></sec></sec><sec sec-type="discussion" id="sec17"><title>Discussion</title><p>This study assessed the familial aggregation and coaggregation, as well as the familiality of and familial correlations between FDs and IDs in a large general population sample. We observed significant aggregation within and between studied disorders. Furthermore, each disorder showed spousal coaggregation with at least one other disorder. Whether this results from assortative mating or shared environment is unknown. We also observed moderate familiality across all disorders, with familial correlations indicating that this familiality is moderately to highly shared between FDs and IDs.</p><sec sec-type="other" id="sec18"><title>Comparison with familial coaggregation studies</title><p>Our results show that individuals with a first-degree relative affected by an ID or an FD are at increased risk of developing the same or other studied disorders, consistent with previous studies on IDs (Hettema, Neale, &#x00026; Kendler, <xref rid="r28" ref-type="bibr">2001</xref>; Sullivan, Neale, &#x00026; Kendler, <xref rid="r60" ref-type="bibr">2000</xref>), FDs (Albright et al., <xref rid="r2" ref-type="bibr">2011</xref>; Saito et al., <xref rid="r54" ref-type="bibr">2010</xref>) and across IDs and FDs (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>; Hudson et al., <xref rid="r29" ref-type="bibr">2004</xref>). Our coaggregation patterns largely resemble those of a medical records-based study in a population registry database (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>). Minor discrepancies, like IBS exhibiting stronger familial aggregation than FM in the previous study (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>) might be due to the severity of IBS cases in medical records. Our sensitivity analysis supports this explanation, as severe IBS that interferes with daily activities showed stronger familial aggregation than noninterfering IBS. A study focusing on FM mirrored our findings with MDD but reported no significant coaggregation with GAD, SPH, PD, or IBS, possibly due to limited sample size and the small number of individuals affected by these disorders (Hudson et al., <xref rid="r29" ref-type="bibr">2004</xref>). In contrast to &#x003bb;<sub>R</sub> in all first-degree relatives, tetrachoric correlations between sibling and parent-offspring pairs in the current study were not always significant, likely due to reduced statistical power and methodological differences. For instance, unlike &#x003bb;<sub>R</sub>, tetrachoric correlations assume an underlying normally distributed liability to disease. Although this is a common assumption in genetic epidemiology, it may not fully reflect the complex familiality of these disorders.</p></sec><sec sec-type="other" id="sec19"><title>Comparison with genetic studies</title><p>We use the terms familiality and familial correlation rather than heritability and genetic correlation because our methods do not disentangle genetic from shared environmental effects. However, evidence suggests that for most disorders, familial aggregation results from genetic factors, with limited impact from shared environmental factors. For instance, in twin studies on IDs, IBS, and FM, models not including a shared environmental component are a better fit for the data than models that do include a shared environmental component (Hettema et al., <xref rid="r28" ref-type="bibr">2001</xref>; Magnusson et al., <xref rid="r41" ref-type="bibr">2024</xref>; Markkula et al., <xref rid="r42" ref-type="bibr">2009</xref>; Sullivan et al., <xref rid="r60" ref-type="bibr">2000</xref>; Svedberg et al., <xref rid="r61" ref-type="bibr">2008</xref>). Additionally, except for SPH and ME/CFS, our familiality estimates from second-degree relatives were very close to those from first-degree relatives (Supplementary <uri xlink:href="http://doi.org/10.1017/S003329172500100X">Table&#x000a0;4</uri>), despite second-degree relatives sharing less of their environment than first-degree relatives. This also suggests a limited role of the shared environment. Moreover, for well-studied disorders like MDD and GAD, our familiality estimates are lower than the heritability estimates from meta-analyses of twin studies (Hettema et al., <xref rid="r28" ref-type="bibr">2001</xref>; Sullivan et al., <xref rid="r60" ref-type="bibr">2000</xref>), which would be unlikely if there were strong shared environmental effects. The familial correlation between MDD and GAD also aligns with the genetic correlation found in a major twin study (Kendler, Gardner, Gatz, &#x00026; Pedersen, <xref rid="r34" ref-type="bibr">2007</xref>). Therefore, we believe that the current study contributes to the growing body of evidence supporting a genetic component in FDs (Ablin &#x00026; Buskila, <xref rid="r1" ref-type="bibr">2015</xref>; Dibble, McGrath, &#x00026; Ponting, <xref rid="r17" ref-type="bibr">2020</xref>; Saito, <xref rid="r53" ref-type="bibr">2011</xref>).</p><p>Our familiality estimates for ME/CFS and IBS are similar to heritability estimates from twin studies (Buchwald et al., <xref rid="r11" ref-type="bibr">2001</xref>; Svedberg et al., <xref rid="r61" ref-type="bibr">2008</xref>). Our familiality estimate for FM is higher than the heritability estimate (23%, 95% CI 14&#x02013;32) of a twin study based on ICD-10 codes for myalgia (muscle pain) and FM (Magnusson et al., <xref rid="r41" ref-type="bibr">2024</xref>). In contrast, our estimate is lower than the estimate (51%, 95% CI: 45&#x02013;56) of a twin study that identified FM through questionnaire items related to symptoms like morning and evening stiffness, neck pain and stiffness, tender points, daytime fatigue, and numbness (Markkula et al., <xref rid="r42" ref-type="bibr">2009</xref>).</p><p>Our findings also suggest that the liability to disease is shared between FDs and IDs, corroborating previous studies (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>; Kato et al., <xref rid="r31" ref-type="bibr">2009</xref>; Kendler et al., <xref rid="r36" ref-type="bibr">2023</xref>). A Swedish twin study identified two latent genetic variables that underlie the comorbidity of MDD, GAD, and FDs (Kato et al., <xref rid="r31" ref-type="bibr">2009</xref>). MDD, GAD, and FDs loaded on one latent genetic variable, which is in line with the familial correlations we found between IDs and FDs. The second latent genetic variable was exclusively related to FDs (Kato et al., <xref rid="r31" ref-type="bibr">2009</xref>), fitting the high familial correlations we found between FDs. Strong correlations between FDs could be because individuals meeting criteria for one FD often report symptoms included in the diagnostic criteria for other FDs (van der Meulen et al., <xref rid="r67" ref-type="bibr">2024</xref>).</p><p>ME/CFS and FM exhibited a closer familial relationship than either had with IBS, while IDs were more linked to ME/CFS than to FM or IBS. These findings parallel the factor loadings of the Swedish twin study (Kato et al., <xref rid="r31" ref-type="bibr">2009</xref>). However, they differ from a family-based Swedish registry study, where FM and ME/CFS were more related to IBS than to each other, and IDs were most associated with FM (Kendler et al., <xref rid="r36" ref-type="bibr">2023</xref>). Similarly, a medical records-based study found that IBS, FM, and MDD showed more extensive overlap with other FDs or MDD in distant relatives than ME/CFS (Allen-Brady et al., <xref rid="r3" ref-type="bibr">2023</xref>). These differences could stem from diagnostic biases (Tattan et al., <xref rid="r63" ref-type="bibr">2024</xref>) and overrepresentation of severe cases in registry/records-based studies, unlike the self-reported symptom assessments in our general population study and the Swedish twin study (Kato et al., <xref rid="r31" ref-type="bibr">2009</xref>).</p></sec><sec sec-type="other" id="sec20"><title>Relevance and future research</title><p>The observed familial coaggregation and familial correlations between FDs and IDs suggest shared etiological mechanisms between these groups of disorders. The specific shared mechanisms remain unknown and most likely reflect multilevel, interlocking etiological pathways (Kendler, <xref rid="r33" ref-type="bibr">2012</xref>). For instance, emotion regulation problems have been linked to IDs, ME/CFS, and FM (Bram, Gottschalk, &#x00026; Leeds, <xref rid="r10" ref-type="bibr">2018</xref>; Pic&#x000f3;-P&#x000e9;rez et al., <xref rid="r47" ref-type="bibr">2017</xref>; Pinto et al., <xref rid="r48" ref-type="bibr">2023</xref>), while inflammation has been associated with FDs and MDD (Andr&#x000e9;s-Rodr&#x000ed;guez et al., <xref rid="r6" ref-type="bibr">2020</xref>; Burns et al., <xref rid="r13" ref-type="bibr">2019</xref>; Harsanyi, Kupcova, Danisovic, &#x00026; Klein, <xref rid="r26" ref-type="bibr">2023</xref>; Strawbridge, Sartor, Scott, &#x00026; Cleare, <xref rid="r59" ref-type="bibr">2019</xref>). Genetic overlap previously found between FDs and somatic disorders further emphasizes the multifaceted nature of FD etiology (Kendler et al., <xref rid="r36" ref-type="bibr">2023</xref>).</p><p>To uncover specific shared biological mechanisms, molecular genetic studies are needed. A GWAS revealed shared loci between IBS and anxiety disorders (Eijsbouts et al., <xref rid="r21" ref-type="bibr">2021</xref>). Genes mapped to shared loci between IBS and anxiety disorders regulate neural circuits and influence white matter microstructure (Eijsbouts et al., <xref rid="r21" ref-type="bibr">2021</xref>) and were enriched for pathways relevant to the nervous and immune system (Tesfaye et al., <xref rid="r65" ref-type="bibr">2023</xref>). While our findings advance the understanding of FDs, extensive molecular genetic studies, including ME/CFS and FM, are needed to identify shared genomic loci, which could unveil the underlying mechanisms common to IDs and FDs.</p><p>Genetic correlations may also stem from a causal link on the symptom level. For instance, sleep dysfunction, which is a symptom of MDD, is a potential trigger for FM (Choy, <xref rid="r14" ref-type="bibr">2015</xref>). Mendelian randomization studies could provide additional understanding of the causal relationship between FDs and IDs (Davey Smith &#x00026; Ebrahim, <xref rid="r16" ref-type="bibr">2004</xref>).</p></sec><sec sec-type="other" id="sec21"><title>Strengths and limitations</title><p>This study&#x02019;s strengths lie in its use of a large population-based cohort and a diagnostic algorithm for assessing self-reported symptoms against official diagnostic criteria. By avoiding registry data, medical center recruitment, or self-reported diagnoses, we minimized the impact of diagnostic biases and help-seeking behavior (Kendler, <xref rid="r32" ref-type="bibr">1995</xref>; Talley &#x00026; Spiller, <xref rid="r62" ref-type="bibr">2002</xref>; Tattan et al., <xref rid="r63" ref-type="bibr">2024</xref>; Wolfe et al., <xref rid="r73" ref-type="bibr">2019</xref>), prevented oversampling of severe cases, and captured cases otherwise being overlooked (Warren &#x00026; Clauw, <xref rid="r71" ref-type="bibr">2012</xref>). Furthermore, the direct assessment of disease status in relatives minimizes potential biases associated with participants reporting on the health of their relatives, addressing concerns related to incomplete knowledge about family members&#x02019; health (Milne et al., <xref rid="r43" ref-type="bibr">2009</xref>; Saito et al., <xref rid="r55" ref-type="bibr">2008</xref>).</p><p>The primary limitation of this study is the potential inaccuracy in estimating disease prevalence among individuals with an affected relative. This arises from several factors. Firstly, we lacked complete data on first-degree relatives for all Lifelines participants, with 41% of participants having no first-degree relatives in the data. These individuals could not be considered for the population of individuals with an affected relative. By including these individuals in the general population estimate, we implicitly assumed they were representative of the general population. However, our data suggest that this might not be the case as disease prevalence was lower among those with relatives in the dataset (<xref rid="tab1" ref-type="table">Table 1</xref>), suggesting that individuals without relatives were less healthy. Recognizing that the number of family members in the data is associated with both our outcome (disease prevalence) and our exposure (having an affected relative), we included the number of relatives in the data as a covariate in our analyses, addressing some of the inaccuracies in prevalence estimation. However, a second limitation is participation bias, as individuals with relatives affected by MDD, GAD, AGPH, PD, IBS, or FM were less likely to participate in subsequent assessment waves. This likely resulted in an underestimation of disease prevalence among those with affected relatives. Moreover, in the absence of lifetime diagnoses, we relied on point-in-time diagnoses. These limitations have possibly led to an underestimation of &#x003bb;<sub>R</sub> and familiality estimates.</p></sec></sec><sec sec-type="conclusions" id="sec22"><title>Conclusion</title><p>In conclusion, our study underscores familial and likely genetic overlap between FDs and IDs, suggesting potential shared etiological mechanisms. To clarify the specific nature of these shared mechanisms and explore potential causal relationships between FDs and IDs, additional studies incorporating genotype data are needed.</p></sec><sec sec-type="supplementary-material" id="sec234"><title>Supporting information</title><supplementary-material id="sm01" position="float" content-type="local-data"><caption><title>Bos et al. supplementary material 1</title><p>Bos et al. supplementary material</p></caption><media xlink:href="S003329172500100Xsup001.docx" id="d67e1141" position="anchor"/></supplementary-material><supplementary-material id="sm02" position="float" content-type="local-data"><caption><title>Bos et al. supplementary material 2</title><p>Bos et al. supplementary material</p></caption><media xlink:href="S003329172500100Xsup002.xlsx" id="d67e1146" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>We thank the members of the Pathways of Functional and Internalizing Disorders (PATHFINDER) consortium for their contributions to this project. The Lifelines Biobank initiative has been made possible by a subsidy from the Dutch Ministry of Health, Welfare and Sport, the Dutch Ministry of Economic Affairs, the University Medical Center Groningen (UMCG the Netherlands), University of Groningen, and the Northern Provinces of the Netherlands. The authors wish to acknowledge the services of the Lifelines Cohort Study, the contributing researchers involved in data collection, and all the study participants.</p></ack><sec sec-type="supplementary-material" id="nts1"><title>Supplementary material</title><p>The supplementary materials for this article can be found at <uri xlink:href="https://doi.org/10.1017/S003329172500100X">https://doi.org/10.1017/S003329172500100X</uri>.</p></sec><sec sec-type="data-availability" id="sec233"><title>Data availability statement</title><p>Code for estimating &#x003bb;<sub>R</sub>, familiality, and familial correlations are available on OSF via doi: <uri xlink:href="https://doi.org/10.17605/OSF.IO/7RCVT">10.17605/OSF.IO/7RCVT</uri>.</p></sec><sec sec-type="funding-statement" id="sec24"><title>Funding statement</title><p>This project was supported by NIMH grant R01MH125902. Hanna van Loo was supported by a Veni grant from the Talent Program of the Netherlands Organization of Scientific Research (NWOZonMW 09150161810021). Judith Rosmalen was supported by a Vici grant from the Talent Program of the Netherlands Organization of Scientific Research (NWO Vici Vi.C.191.021).</p></sec><sec sec-type="COI-statement" id="sec25"><title>Competing interests</title><p>We declare no conflicts of interest.</p></sec><ref-list id="refs1" content-type="normal"><title>Bibliography</title><ref id="r1"><mixed-citation publication-type="journal" id="ref1"><string-name><surname>Ablin</surname>, <given-names>J. N.</given-names></string-name>, &#x00026; <string-name><surname>Buskila</surname>, <given-names>D.</given-names></string-name> (<year>2015</year>). <article-title>Update on the genetics of the fibromyalgia syndrome</article-title>. <source>Best Practice &#x00026; Research Clinical Rheumatology</source>, <volume>29</volume>(<issue>1</issue>), <fpage>20</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.berh.2015.04.018</pub-id><pub-id pub-id-type="pmid">26266996</pub-id>
</mixed-citation></ref><ref id="r2"><mixed-citation publication-type="journal" id="ref2"><string-name><surname>Albright</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Light</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Light</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bateman</surname>, <given-names>L.</given-names></string-name>, &#x00026; <string-name><surname>Cannon-Albright</surname>, <given-names>L. A.</given-names></string-name> (<year>2011</year>). <article-title>Evidence for a heritable predisposition to chronic fatigue syndrome</article-title>. <source>BMC Neurology</source>, <volume>11</volume>, <fpage>62</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2377-11-62</pub-id><pub-id pub-id-type="pmid">21619629</pub-id>
</mixed-citation></ref><ref id="r3"><mixed-citation publication-type="journal" id="ref3"><string-name><surname>Allen-Brady</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Fyer</surname>, <given-names>A. J.</given-names></string-name>, &#x00026; <string-name><surname>Weissman</surname>, <given-names>M.</given-names></string-name> (<year>2023</year>). <article-title>The multi-generational familial aggregation of interstitial cystitis, other chronic nociplastic pain disorders, depression, and panic disorder</article-title>. <source>Psychological Medicine</source>, <volume>53</volume>(<issue>16</issue>), <fpage>7847</fpage>&#x02013;<lpage>7856</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291723001885</pub-id><pub-id pub-id-type="pmid">37458197</pub-id>
</mixed-citation></ref><ref id="r4"><mixed-citation publication-type="book" id="ref4"><collab>American Psychiatric Association</collab> (Ed.) (<year>1998</year>). <source>Diagnostic and statistical manual of mental disorders: DSM-IV&#x000a0;; includes ICD-9-CM codes effective 1</source>. <edition>(4th ed., 7th print)</edition>. <publisher-loc>Washington, DC</publisher-loc>.: <publisher-name>APA</publisher-name></mixed-citation></ref><ref id="r5"><mixed-citation publication-type="book" id="ref5"><collab>American Psychiatric Association</collab> (Ed.) (<year>2000</year>). <source>Diagnostic and statistical manual of mental disorders fourth edition text revision (DSM-IV-TR)</source> (4th ed., 9. print). <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>APA</publisher-name></mixed-citation></ref><ref id="r6"><mixed-citation publication-type="journal" id="ref6"><string-name><surname>Andr&#x000e9;s-Rodr&#x000ed;guez</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Borr&#x000e0;s</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Feliu-Soler</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>P&#x000e9;rez-Aranda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Angarita-Osorio</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Moreno-Peral</surname>, <given-names>P.</given-names></string-name>, &#x02026; <string-name><surname>Luciano</surname>, <given-names>J. V</given-names></string-name>. (<year>2020</year>). <article-title>Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression</article-title>. <source>Brain, Behavior, and Immunity</source>, <volume>87</volume>, <fpage>881</fpage>&#x02013;<lpage>889</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2019.12.020</pub-id><pub-id pub-id-type="pmid">31887417</pub-id>
</mixed-citation></ref><ref id="r80"><mixed-citation publication-type="journal" id="ref80"><string-name><surname>Arel-Bundock</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Greifer</surname>, <given-names>N.</given-names></string-name>, &#x00026; <string-name><surname>Heiss</surname>, <given-names>A.</given-names></string-name> (<year>2024</year>). <article-title>How to Interpret Statistical Models Using marginaleffects for R and Python</article-title>. <source>Journal of Statistical Software</source>, <volume>111</volume>(<issue>9</issue>), <fpage>1</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v111.i09</pub-id></mixed-citation></ref><ref id="r7"><mixed-citation publication-type="journal" id="ref7"><string-name><surname>Babchishin</surname>, <given-names>K. M.</given-names></string-name>, &#x00026; <string-name><surname>Helmus</surname>, <given-names>L.-M.</given-names></string-name> (<year>2016</year>). <article-title>The influence of base rates on correlations: An evaluation of proposed alternative effect sizes with real-world data</article-title>. <source>Behavior Research Methods</source>, <volume>48</volume>(<issue>3</issue>), <fpage>1021</fpage>&#x02013;<lpage>1031</lpage>. <pub-id pub-id-type="doi">10.3758/s13428-015-0627-7</pub-id><pub-id pub-id-type="pmid">26182856</pub-id>
</mixed-citation></ref><ref id="r8"><mixed-citation publication-type="journal" id="ref8"><string-name><surname>Baselmans</surname>, <given-names>B. M. L.</given-names></string-name>, <string-name><surname>Yengo</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>van Rheenen</surname>, <given-names>W.</given-names></string-name>, &#x00026; <string-name><surname>Wray</surname>, <given-names>N. R</given-names></string-name>. (<year>2021</year>). <article-title>Risk in relatives, heritability, SNP-based heritability, and genetic correlations in psychiatric disorders: A review</article-title>. <source>Biological Psychiatry</source>, <volume>89</volume>(<issue>1</issue>), <fpage>11</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2020.05.034</pub-id><pub-id pub-id-type="pmid">32736793</pub-id>
</mixed-citation></ref><ref id="r9"><mixed-citation publication-type="journal" id="ref9"><string-name><surname>Bonfiglio</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Henstr&#x000f6;m</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nag</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hadizadeh</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Cenit</surname>, <given-names>M. C.</given-names></string-name>, &#x02026; <string-name><surname>D&#x02019;Amato</surname>, <given-names>M.</given-names></string-name> (<year>2018</year>). <article-title>A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome</article-title>. <source>Neurogastroenterology and Motility</source>, <volume>30</volume>(<issue>9</issue>), <fpage>e13358</fpage>. <pub-id pub-id-type="doi">10.1111/nmo.13358</pub-id><pub-id pub-id-type="pmid">29673008</pub-id>
</mixed-citation></ref><ref id="r10"><mixed-citation publication-type="journal" id="ref10"><string-name><surname>Bram</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Gottschalk</surname>, <given-names>K. A.</given-names></string-name>, &#x00026; <string-name><surname>Leeds</surname>, <given-names>W. M.</given-names></string-name> (<year>2018</year>). <article-title>Emotional regulation in women with chronic fatigue syndrome and depression: Internal representations and adaptive defenses</article-title>. <source>Journal of the American Psychoanalytic Association</source>, <volume>66</volume>(<issue>4</issue>), <fpage>701</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1177/0003065118798043</pub-id><pub-id pub-id-type="pmid">30249136</pub-id>
</mixed-citation></ref><ref id="r11"><mixed-citation publication-type="journal" id="ref11"><string-name><surname>Buchwald</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Herrell</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ashton</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Belcourt</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schmaling</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sullivan</surname>, <given-names>P.</given-names></string-name>, &#x02026; <string-name><surname>Goldberg</surname>, <given-names>J</given-names></string-name>. (<year>2001</year>). <article-title>A twin study of chronic fatigue</article-title>. <source>Psychosomatic Medicine</source>, <volume>63</volume>(<issue>6</issue>), <fpage>936</fpage>&#x02013;<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1097/00006842-200111000-00012</pub-id><pub-id pub-id-type="pmid">11719632</pub-id>
</mixed-citation></ref><ref id="r12"><mixed-citation publication-type="journal" id="ref12"><string-name><surname>Buist-Bouwman</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>De Graaf</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Vollebergh</surname>, <given-names>W. a. M</given-names>.</string-name>, <string-name><surname>Alonso</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bruffaerts</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ormel</surname>, <given-names>J.</given-names></string-name>, &#x00026; <collab>ESEMeD/MHEDEA 2000 Investigators</collab>. (<year>2006</year>). <article-title>Functional disability of mental disorders and comparison with physical disorders: A study among the general population of six European countries</article-title>. <source>Acta Psychiatrica Scandinavica</source>, <volume>113</volume>(<issue>6</issue>), <fpage>492</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.2005.00684.x</pub-id><pub-id pub-id-type="pmid">16677226</pub-id>
</mixed-citation></ref><ref id="r13"><mixed-citation publication-type="journal" id="ref13"><string-name><surname>Burns</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Carroll</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mathe</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Horvat</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Foster</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Walker</surname>, <given-names>M. M.</given-names></string-name>, &#x02026; <string-name><surname>Keely</surname>, <given-names>S.</given-names></string-name> (<year>2019</year>). <article-title>Evidence for local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome: A systematic review</article-title>. <source>Official Journal of the American College of Gastroenterology|ACG</source>, <volume>114</volume>(<issue>3</issue>), <fpage>429</fpage>. <pub-id pub-id-type="doi">10.1038/s41395-018-0377-0</pub-id></mixed-citation></ref><ref id="r14"><mixed-citation publication-type="journal" id="ref14"><string-name><surname>Choy</surname>, <given-names>E. H. S.</given-names></string-name> (<year>2015</year>). <article-title>The role of sleep in pain and fibromyalgia</article-title>. <source>Nature Reviews Rheumatology</source>, <volume>11</volume>(<issue>9</issue>), <fpage>513</fpage>&#x02013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2015.56</pub-id><pub-id pub-id-type="pmid">25907704</pub-id>
</mixed-citation></ref><ref id="r15"><mixed-citation publication-type="journal" id="ref15"><string-name><surname>Cummings</surname>, <given-names>P</given-names></string-name>. (<year>2009</year>). <article-title>The relative merits of risk ratios and odds ratios</article-title>. <source>Archives of Pediatrics &#x00026; Adolescent Medicine</source>, <volume>163</volume>(<issue>5</issue>), <fpage>438</fpage>&#x02013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1001/archpediatrics.2009.31</pub-id><pub-id pub-id-type="pmid">19414690</pub-id>
</mixed-citation></ref><ref id="r16"><mixed-citation publication-type="journal" id="ref16"><string-name><surname>Davey Smith</surname>, <given-names>G.</given-names></string-name>, &#x00026; <string-name><surname>Ebrahim</surname>, <given-names>S.</given-names></string-name> (<year>2004</year>). <article-title>Mendelian randomization: Prospects, potentials, and limitations</article-title>. <source>International Journal of Epidemiology</source>, <volume>33</volume>(<issue>1</issue>), <fpage>30</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyh132</pub-id><pub-id pub-id-type="pmid">15075143</pub-id>
</mixed-citation></ref><ref id="r17"><mixed-citation publication-type="journal" id="ref17"><string-name><surname>Dibble</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>McGrath</surname>, <given-names>S. J.</given-names></string-name>, &#x00026; <string-name><surname>Ponting</surname>, <given-names>C. P.</given-names></string-name> (<year>2020</year>). <article-title>Genetic risk factors of ME/CFS: A critical review</article-title>. <source>Human Molecular Genetics</source>, <volume>29</volume>(<issue>R1</issue>), <fpage>R117</fpage>&#x02013;<lpage>R124</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddaa169</pub-id><pub-id pub-id-type="pmid">32744306</pub-id>
</mixed-citation></ref><ref id="r18"><mixed-citation publication-type="journal" id="ref18"><string-name><surname>Drossman</surname>, <given-names>D. A.</given-names></string-name> (<year>2006</year>). <article-title>The functional gastrointestinal disorders and the Rome III process</article-title>. <source>Gastroenterology</source>, <volume>130</volume>(<issue>5</issue>), <fpage>1377</fpage>&#x02013;<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2006.03.008</pub-id><pub-id pub-id-type="pmid">16678553</pub-id>
</mixed-citation></ref><ref id="r19"><mixed-citation publication-type="journal" id="ref19"><string-name><surname>Drossman</surname>, <given-names>D. A</given-names></string-name>. (<year>2016</year>). <article-title>Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV</article-title>. <source>Gastroenterology</source>, <volume>S0016-5085</volume>(<issue>16</issue>) 00223-7. <pub-id pub-id-type="doi">10.1053/j.gastro.2016.02.032</pub-id></mixed-citation></ref><ref id="r20"><mixed-citation publication-type="journal" id="ref20"><string-name><surname>Dutta</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Brummett</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Moser</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Fritsche</surname>, <given-names>L. G.</given-names></string-name>, <string-name><surname>Tsodikov</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.</given-names></string-name>, &#x02026; <string-name><surname>Scott</surname>, <given-names>L. J.</given-names></string-name> (<year>2020</year>). <article-title>Heritability of the fibromyalgia phenotype varies by Age</article-title>. <source>Arthritis &#x00026; Rheumatology</source>, <volume>72</volume>(<issue>5</issue>), <fpage>815</fpage>&#x02013;<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1002/art.41171</pub-id><pub-id pub-id-type="pmid">31736264</pub-id>
</mixed-citation></ref><ref id="r21"><mixed-citation publication-type="journal" id="ref21"><string-name><surname>Eijsbouts</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kennedy</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Bonfiglio</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Moutsianas</surname>, <given-names>L.</given-names></string-name>, &#x02026; <string-name><surname>Parkes</surname>, <given-names>M.</given-names></string-name> (<year>2021</year>). <article-title>Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders</article-title>. <source>Nature Genetics</source>, <volume>53</volume>(<issue>11</issue>), <fpage>1543</fpage>&#x02013;<lpage>1552</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-021-00950-8</pub-id><pub-id pub-id-type="pmid">34741163</pub-id>
</mixed-citation></ref><ref id="r22"><mixed-citation publication-type="journal" id="ref22"><string-name><surname>Falconer</surname>, <given-names>D. S.</given-names></string-name> (<year>1965</year>). <article-title>The inheritance of liability to certain diseases, estimated from the incidence among relatives</article-title>. <source>Annals of Human Genetics</source>, <volume>29</volume>(<issue>1</issue>), <fpage>51</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-1809.1965.tb00500.x</pub-id></mixed-citation></ref><ref id="r23"><mixed-citation publication-type="journal" id="ref23"><string-name><surname>Fukuda</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Straus</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Hickie</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Sharpe</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Dobbins</surname>, <given-names>J. G.</given-names></string-name>, &#x00026; <string-name><surname>Komaroff</surname>, <given-names>A.</given-names></string-name> (<year>1994</year>). <article-title>The chronic fatigue syndrome: A comprehensive approach to its definition and study</article-title>. <source>International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine</source>, <volume>121</volume>(<issue>12</issue>), <fpage>953</fpage>&#x02013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-121-12-199412150-00009</pub-id></mixed-citation></ref><ref id="r24"><mixed-citation publication-type="journal" id="ref24"><string-name><surname>Hajdarevic</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lande</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mehlsen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Rydland</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sosa</surname>, <given-names>D. D.</given-names></string-name>, <string-name><surname>Strand</surname>, <given-names>E. B.</given-names></string-name>, &#x02026; <string-name><surname>Viken</surname>, <given-names>M. K.</given-names></string-name> (<year>2022</year>). <article-title>Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci</article-title>. <source>Brain, Behavior, and Immunity</source>, <volume>102</volume>, <fpage>362</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2022.03.010</pub-id><pub-id pub-id-type="pmid">35318112</pub-id>
</mixed-citation></ref><ref id="r25"><mixed-citation publication-type="journal" id="ref25"><string-name><surname>Haller</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Cramer</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lauche</surname>, <given-names>R.</given-names></string-name>, &#x00026; <string-name><surname>Dobos</surname>, <given-names>G.</given-names></string-name> (<year>2015</year>). <article-title>Somatoform disorders and medically unexplained symptoms in primary care</article-title>. <source>Deutsches Arzteblatt International</source>, <volume>112</volume>(<issue>16</issue>), <fpage>279</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.3238/arztebl.2015.0279</pub-id><pub-id pub-id-type="pmid">25939319</pub-id>
</mixed-citation></ref><ref id="r26"><mixed-citation publication-type="journal" id="ref26"><string-name><surname>Harsanyi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kupcova</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Danisovic</surname>, <given-names>L.</given-names></string-name>, &#x00026; <string-name><surname>Klein</surname>, <given-names>M.</given-names></string-name> (<year>2023</year>). <article-title>Selected biomarkers of depression: What are the effects of cytokines and inflammation?</article-title>
<source>International Journal of Molecular Sciences</source>, <volume>24</volume>(<issue>1</issue>), <fpage>578</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24010578</pub-id></mixed-citation></ref><ref id="r27"><mixed-citation publication-type="journal" id="ref27"><string-name><surname>Heidari</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Afshari</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Moosazadeh</surname>, <given-names>M.</given-names></string-name> (<year>2017</year>). <article-title>Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis</article-title>. <source>Rheumatology International</source>, <volume>37</volume>(<issue>9</issue>), <fpage>1527</fpage>&#x02013;<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-017-3725-2</pub-id><pub-id pub-id-type="pmid">28447207</pub-id>
</mixed-citation></ref><ref id="r28"><mixed-citation publication-type="journal" id="ref28"><string-name><surname>Hettema</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Neale</surname>, <given-names>M. C.</given-names></string-name>, &#x00026; <string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name> (<year>2001</year>). <article-title>A review and meta-analysis of the genetic epidemiology of anxiety disorders</article-title>. <source>American Journal of Psychiatry</source>, <volume>158</volume>(<issue>10</issue>), <fpage>1568</fpage>&#x02013;<lpage>1578</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.158.10.1568</pub-id><pub-id pub-id-type="pmid">11578982</pub-id>
</mixed-citation></ref><ref id="r29"><mixed-citation publication-type="journal" id="ref29"><string-name><surname>Hudson</surname>, <given-names>J. I.</given-names></string-name>, <string-name><surname>Arnold</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Keck</surname>, <given-names>P. E.</given-names></string-name>, <string-name><surname>Auchenbach</surname>, <given-names>M. B.</given-names></string-name>, &#x00026; <string-name><surname>Pope</surname>, <given-names>H. G</given-names></string-name>. (<year>2004</year>). <part-title>Family study of fibromyalgia and affective spectrum disorder</part-title>. <source>Biological Psychiatry</source>, <volume>56</volume>(<issue>11</issue>), <fpage>884</fpage>&#x02013;<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2004.08.009</pub-id><pub-id pub-id-type="pmid">15576066</pub-id>
</mixed-citation></ref><ref id="r30"><mixed-citation publication-type="journal" id="ref30"><string-name><surname>Joustra</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Janssens</surname>, <given-names>K. A. M.</given-names></string-name>, <string-name><surname>B&#x000fc;ltmann</surname>, <given-names>U.</given-names></string-name>, &#x00026; <string-name><surname>Rosmalen</surname>, <given-names>J. G. M.</given-names></string-name> (<year>2015</year>). <article-title>Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>79</volume>(<issue>2</issue>), <fpage>94</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychores.2015.05.004</pub-id><pub-id pub-id-type="pmid">26026696</pub-id>
</mixed-citation></ref><ref id="r31"><mixed-citation publication-type="journal" id="ref31"><string-name><surname>Kato</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sullivan</surname>, <given-names>P. F.</given-names></string-name>, <string-name><surname>Eveng&#x000e5;rd</surname>, <given-names>B.</given-names></string-name>, &#x00026; <string-name><surname>Pedersen</surname>, <given-names>N. L.</given-names></string-name> (<year>2009</year>). <article-title>A population-based twin study of functional somatic syndromes</article-title>. <source>Psychological Medicine</source>, <volume>39</volume>(<issue>3</issue>), <fpage>497</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291708003784</pub-id><pub-id pub-id-type="pmid">18578896</pub-id>
</mixed-citation></ref><ref id="r32"><mixed-citation publication-type="journal" id="ref32"><string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name> (<year>1995</year>). <article-title>Is seeking treatment for depression predicted by a history of depression in relatives? Implications for family studies of affective disorder</article-title>. <source>Psychological Medicine</source>, <volume>25</volume>(<issue>4</issue>), <fpage>807</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291700035054</pub-id><pub-id pub-id-type="pmid">7480458</pub-id>
</mixed-citation></ref><ref id="r33"><mixed-citation publication-type="journal" id="ref33"><string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name> (<year>2012</year>). <article-title>The dappled nature of causes of psychiatric illness: Replacing the organic&#x02013;functional/hardware&#x02013;software dichotomy with empirically based pluralism</article-title>. <source>Molecular Psychiatry</source>, <volume>17</volume>(<issue>4</issue>), <fpage>377</fpage>&#x02013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2011.182</pub-id><pub-id pub-id-type="pmid">22230881</pub-id>
</mixed-citation></ref><ref id="r34"><mixed-citation publication-type="journal" id="ref34"><string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Gardner</surname>, <given-names>C. O.</given-names></string-name>, <string-name><surname>Gatz</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Pedersen</surname>, <given-names>N. L.</given-names></string-name> (<year>2007</year>). <article-title>The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample</article-title>. <source>Psychological Medicine</source>, <volume>37</volume>(<issue>3</issue>), <fpage>453</fpage>&#x02013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291706009135</pub-id><pub-id pub-id-type="pmid">17121688</pub-id>
</mixed-citation></ref><ref id="r35"><mixed-citation publication-type="journal" id="ref35"><string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name>, &#x00026; <string-name><surname>Neale</surname>, <given-names>M. C.</given-names></string-name> (<year>2009</year>). &#x0201c;<article-title>Familiality&#x0201d; or heritability</article-title>. <source>Archives of General Psychiatry</source>, <volume>66</volume>(<issue>4</issue>), <fpage>452</fpage>&#x02013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.14</pub-id></mixed-citation></ref><ref id="r36"><mixed-citation publication-type="journal" id="ref36"><string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Rosmalen</surname>, <given-names>J. G. M.</given-names></string-name>, <string-name><surname>Ohlsson</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sundquist</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Sundquist</surname>, <given-names>K.</given-names></string-name> (<year>2023</year>). <article-title>A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression</article-title>. <source>Psychological Medicine</source>, <volume>53</volume>(<issue>9</issue>), <fpage>3879</fpage>&#x02013;<lpage>3886</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291722000526</pub-id><pub-id pub-id-type="pmid">35354508</pub-id>
</mixed-citation></ref><ref id="r37"><mixed-citation publication-type="journal" id="ref37"><string-name><surname>Kleinst&#x000e4;uber</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schr&#x000f6;der</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Daehler</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pallesen</surname>, <given-names>K. J.</given-names></string-name>, <string-name><surname>Rask</surname>, <given-names>C. U.</given-names></string-name>, <string-name><surname>Sanyer</surname>, <given-names>M.</given-names></string-name>, &#x02026; <string-name><surname>Rosmalen</surname>, <given-names>J. G. M.</given-names></string-name> (<year>2023</year>). <article-title>Aetiological understanding of fibromyalgia, irritable bowel syndrome, chronic fatigue syndrome and classificatory analogues: A systematic umbrella review</article-title>. <source>Clinical Psychology in Europe</source>, <volume>5</volume>(<issue>3</issue>), <fpage>1</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.32872/cpe.11179</pub-id></mixed-citation></ref><ref id="r38"><mixed-citation publication-type="journal" id="ref38"><string-name><surname>Konnopka</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schaefert</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Heinrich</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kaufmann</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Luppa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Herzog</surname>, <given-names>W.</given-names></string-name>, &#x00026; <string-name><surname>K&#x000f6;nig</surname>, <given-names>H.-H.</given-names></string-name> (<year>2012</year>). <article-title>Economics of medically unexplained symptoms: A systematic review of the literature</article-title>. <source>Psychotherapy and Psychosomatics</source>, <volume>81</volume>(<issue>5</issue>), <fpage>265</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1159/000337349</pub-id><pub-id pub-id-type="pmid">22832397</pub-id>
</mixed-citation></ref><ref id="r40"><mixed-citation publication-type="journal" id="ref40"><string-name><surname>Lim</surname>, <given-names>E.-J.</given-names></string-name>, <string-name><surname>Ahn</surname>, <given-names>Y.-C.</given-names></string-name>, <string-name><surname>Jang</surname>, <given-names>E.-S.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.-W.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.-H.</given-names></string-name>, &#x00026; <string-name><surname>Son</surname>, <given-names>C.-G.</given-names></string-name> (<year>2020</year>). <article-title>Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)</article-title>. <source>Journal of Translational Medicine</source>, <volume>18</volume>(<issue>1</issue>), <fpage>100</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-020-02269-0</pub-id><pub-id pub-id-type="pmid">32093722</pub-id>
</mixed-citation></ref><ref id="r41"><mixed-citation publication-type="journal" id="ref41"><string-name><surname>Magnusson</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Turkiewicz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ryd&#x000e9;n</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Englund</surname>, <given-names>M.</given-names></string-name> (<year>2024</year>). <article-title>Genetic influence on osteoarthritis versus other rheumatic diseases</article-title>. <source>Arthritis &#x00026; Rheumatology</source>, <volume>76</volume>(<issue>2</issue>), <fpage>206</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1002/art.42696</pub-id><pub-id pub-id-type="pmid">37691153</pub-id>
</mixed-citation></ref><ref id="r42"><mixed-citation publication-type="journal" id="ref42"><string-name><surname>Markkula</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>J&#x000e4;rvinen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Leino-Arjas</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Koskenvuo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kalso</surname>, <given-names>E.</given-names></string-name>, &#x00026; <string-name><surname>Kaprio</surname>, <given-names>J.</given-names></string-name> (<year>2009</year>). <article-title>Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort</article-title>. <source>European Journal of Pain (London, England)</source>, <volume>13</volume>(<issue>7</issue>), <fpage>744</fpage>&#x02013;<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpain.2008.09.007</pub-id><pub-id pub-id-type="pmid">18938094</pub-id>
</mixed-citation></ref><ref id="r43"><mixed-citation publication-type="journal" id="ref43"><string-name><surname>Milne</surname>, <given-names>B. J.</given-names></string-name>, <string-name><surname>Caspi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Crump</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Poulton</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Rutter</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sears</surname>, <given-names>M. R.</given-names></string-name>, &#x00026; <string-name><surname>Moffitt</surname>, <given-names>T. E.</given-names></string-name> (<year>2009</year>). <article-title>The validity of the family history screen for assessing family history of mental disorders</article-title>. <source>American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics</source>, <volume>150</volume>(<issue>1</issue>), <fpage>41</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30764</pub-id></mixed-citation></ref><ref id="r44"><mixed-citation publication-type="journal" id="ref44"><string-name><surname>Moscati</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Faucon</surname>, <given-names>A. B.</given-names></string-name>, <string-name><surname>Arnaiz-Y&#x000e9;pez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>L&#x000f6;nn</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Sundquist</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sundquist</surname>, <given-names>K.</given-names></string-name>, &#x02026; <string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name> (<year>2023</year>). <article-title>Life is pain: Fibromyalgia as a nexus of multiple liability distributions</article-title>. <source>American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics</source>, <volume>192</volume>(<issue>7&#x02013;8</issue>), <fpage>171</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32949</pub-id><pub-id pub-id-type="pmid">37334860</pub-id>
</mixed-citation></ref><ref id="r45"><mixed-citation publication-type="book" id="ref45"><string-name><surname>Muth&#x000e9;n</surname>, <given-names>L.</given-names></string-name>, &#x00026; <string-name><surname>Muth&#x000e9;n</surname>, <given-names>B</given-names></string-name>. (<year>1998</year>). <source>Mplus user&#x02019;s guide</source>. (8th ed). <publisher-loc>Los Angeles, CA</publisher-loc>: <publisher-name>Muth&#x000e9;n &#x00026; Muth&#x000e9;n</publisher-name>.</mixed-citation></ref><ref id="r46"><mixed-citation publication-type="journal" id="ref46"><string-name><surname>Nimnuan</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hotopf</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Wessely</surname>, <given-names>S</given-names></string-name>. (<year>2001</year>). <article-title>Medically unexplained symptoms: An epidemiological study in seven specialities</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>51</volume>(<issue>1</issue>), <fpage>361</fpage>&#x02013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3999(01)00223-9</pub-id><pub-id pub-id-type="pmid">11448704</pub-id>
</mixed-citation></ref><ref id="r47"><mixed-citation publication-type="journal" id="ref47"><string-name><surname>Pic&#x000f3;-P&#x000e9;rez</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Radua</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Steward</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Mench&#x000f3;n</surname>, <given-names>J. M.</given-names></string-name>, &#x00026; <string-name><surname>Soriano-Mas</surname>, <given-names>C</given-names></string-name>. (<year>2017</year>). <article-title>Emotion regulation in mood and anxiety disorders: A meta-analysis of fMRI cognitive reappraisal studies</article-title>. <source>Progress in Neuro-Psychopharmacology and Biological Psychiatry</source>, <volume>79</volume>, <fpage>96</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.06.001</pub-id><pub-id pub-id-type="pmid">28579400</pub-id>
</mixed-citation></ref><ref id="r48"><mixed-citation publication-type="journal" id="ref48"><string-name><surname>Pinto</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Geenen</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wager</surname>, <given-names>T. D.</given-names></string-name>, <string-name><surname>Lumley</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>H&#x000e4;user</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kosek</surname>, <given-names>E.</given-names></string-name>, &#x02026; <string-name><surname>da Silva</surname>, <given-names>J. A. P.</given-names></string-name> (<year>2023</year>). <article-title>Emotion regulation and the salience network: A hypothetical integrative model of fibromyalgia</article-title>. <source>Nature Reviews Rheumatology</source>, <volume>19</volume>(<issue>1</issue>), <fpage>44</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/s41584-022-00873-6</pub-id><pub-id pub-id-type="pmid">36471023</pub-id>
</mixed-citation></ref><ref id="r49"><mixed-citation publication-type="book" id="ref49"><collab>R Core Team</collab>. (<year>2022</year>). <source>R: The R project for statistical computing</source>. <publisher-loc>Vienna, Austria</publisher-loc>.: <publisher-name>R Foundation for Statistical Computing</publisher-name>. <uri xlink:href="https://www.r-project.org/">https://www.r-project.org/</uri></mixed-citation></ref><ref id="r50"><mixed-citation publication-type="journal" id="ref50"><string-name><surname>Reich</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>James</surname>, <given-names>J. W.</given-names></string-name>, &#x00026; <string-name><surname>Morris</surname>, <given-names>C. A</given-names></string-name>. (<year>1972</year>). <article-title>The use of multiple thresholds in determining the mode of transmission of semi-continuous traits</article-title>. <source>Annals of Human Genetics</source>, <volume>36</volume>(<issue>2</issue>), <fpage>163</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-1809.1972.tb00767.x</pub-id><pub-id pub-id-type="pmid">4676360</pub-id>
</mixed-citation></ref><ref id="r51"><mixed-citation publication-type="journal" id="ref51"><string-name><surname>Risch</surname>, <given-names>N</given-names></string-name>. (<year>1990</year>). <article-title>Linkage strategies for genetically complex traits. I. Multilocus models</article-title>. <source>American Journal of Human Genetics</source>, <volume>46</volume>(<issue>2</issue>), <fpage>222</fpage>&#x02013;<lpage>228</lpage>.<pub-id pub-id-type="pmid">2301392</pub-id>
</mixed-citation></ref><ref id="r52"><mixed-citation publication-type="journal" id="ref52"><string-name><surname>Rometsch</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Mansueto</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Maas Genannt Bermpohl</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Cosci</surname>, <given-names>F</given-names></string-name>. (<year>2024</year>). <article-title>Prevalence of functional disorders across Europe: A systematic review and meta-analysis</article-title>. <source>European Journal of Epidemiology</source>. <pub-id pub-id-type="doi">10.1007/s10654-024-01109-5</pub-id></mixed-citation></ref><ref id="r53"><mixed-citation publication-type="journal" id="ref53"><string-name><surname>Saito</surname>, <given-names>Y. A.</given-names></string-name> (<year>2011</year>). <article-title>The role of genetics in IBS</article-title>. <source>Gastroenterology Clinics of North America</source>, <volume>40</volume>(<issue>1</issue>), <fpage>45</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.gtc.2010.12.011</pub-id><pub-id pub-id-type="pmid">21333900</pub-id>
</mixed-citation></ref><ref id="r54"><mixed-citation publication-type="journal" id="ref54"><string-name><surname>Saito</surname>, <given-names>Y. A.</given-names></string-name>, <string-name><surname>Petersen</surname>, <given-names>G. M.</given-names></string-name>, <string-name><surname>Larson</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Atkinson</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Fridley</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>de Andrade</surname>, <given-names>M.</given-names></string-name>, &#x02026; <string-name><surname>Talley</surname>, <given-names>N. J</given-names></string-name>. (<year>2010</year>). <article-title>Familial aggregation of irritable bowel syndrome: A family case&#x02013;control study</article-title>. <source>The American Journal of Gastroenterology</source>, <volume>105</volume>(<issue>4</issue>), <fpage>833</fpage>&#x02013;<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2010.116</pub-id><pub-id pub-id-type="pmid">20234344</pub-id>
</mixed-citation></ref><ref id="r55"><mixed-citation publication-type="journal" id="ref55"><string-name><surname>Saito</surname>, <given-names>Y. A.</given-names></string-name>, <string-name><surname>Zimmerman</surname>, <given-names>J. M.</given-names></string-name>, <string-name><given-names>S.</given-names>
<surname>Harmsen</surname></string-name>, W., <string-name><surname>De Andrade</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Locke</surname>
<suffix>Iii</suffix>, <given-names>G. R.</given-names></string-name>, <string-name><surname>Petersen</surname>, <given-names>G. M.</given-names></string-name>, &#x00026; <string-name><surname>Talley</surname>, <given-names>N. J</given-names></string-name>. (<year>2008</year>). <article-title>Irritable bowel syndrome aggregates strongly in families: A family-based case-control study</article-title>. <source>Neurogastroenterology &#x00026; Motility</source>, <volume>20</volume>(<issue>7</issue>), <fpage>790</fpage>&#x02013;<lpage>797</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2982.2007.01077.x</pub-id><pub-id pub-id-type="pmid">18221250</pub-id>
</mixed-citation></ref><ref id="r56"><mixed-citation publication-type="journal" id="ref56"><string-name><surname>Sheehan</surname>, <given-names>D. V.</given-names></string-name>, <string-name><surname>Lecrubier</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Sheehan</surname>, <given-names>K. H.</given-names></string-name>, <string-name><surname>Amorim</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Janavs</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Weiller</surname>, <given-names>E.</given-names></string-name>, &#x02026; <string-name><surname>Dunbar</surname>, <given-names>G. C</given-names></string-name>. (<year>1998</year>). <article-title>The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source>The Journal of Clinical Psychiatry</source>, <volume>59</volume>(<issue>suppl 20</issue>), <fpage>11980</fpage>.</mixed-citation></ref><ref id="r57"><mixed-citation publication-type="journal" id="ref57"><string-name><surname>Sijtsma</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rienks</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>van der Harst</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Navis</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Rosmalen</surname>, <given-names>J. G. M.</given-names></string-name>, &#x00026; <string-name><surname>Dotinga</surname>, <given-names>A</given-names></string-name>. (<year>2022</year>). <article-title>Cohort profile update: Lifelines, a three-generation cohort study and biobank</article-title>. <source>International Journal of Epidemiology</source>, <volume>51</volume>(<issue>5</issue>), <fpage>e295</fpage>&#x02013;<lpage>e302</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyab257</pub-id><pub-id pub-id-type="pmid">34897450</pub-id>
</mixed-citation></ref><ref id="r58"><mixed-citation publication-type="journal" id="ref58"><string-name><surname>Steinhausen</surname>, <given-names>H.-C.</given-names></string-name>, <string-name><surname>Jakobsen</surname>, <given-names>H.</given-names></string-name>, &#x00026; <string-name><surname>Munk-J&#x000f8;rgensen</surname>, <given-names>P</given-names></string-name>. (<year>2017</year>). <article-title>Family aggregation and risk factors in substance use disorders over three generations in a nation-wide study</article-title>. <source>PloS One</source>, <volume>12</volume>(<issue>5</issue>), <fpage>e0177700</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0177700</pub-id><pub-id pub-id-type="pmid">28545101</pub-id>
</mixed-citation></ref><ref id="r59"><mixed-citation publication-type="journal" id="ref59"><string-name><surname>Strawbridge</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Sartor</surname>, <given-names>M.-L.</given-names></string-name>, <string-name><surname>Scott</surname>, <given-names>F.</given-names></string-name>, &#x00026; <string-name><surname>Cleare</surname>, <given-names>A. J</given-names></string-name>. (<year>2019</year>). <article-title>Inflammatory proteins are altered in chronic fatigue syndrome&#x02014;A systematic review and meta-analysis</article-title>. <source>Neuroscience &#x00026; Biobehavioral Reviews</source>, <volume>107</volume>, <fpage>69</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2019.08.011</pub-id><pub-id pub-id-type="pmid">31465778</pub-id>
</mixed-citation></ref><ref id="r60"><mixed-citation publication-type="journal" id="ref60"><string-name><surname>Sullivan</surname>, <given-names>P. F.</given-names></string-name>, <string-name><surname>Neale</surname>, <given-names>M. C.</given-names></string-name>, &#x00026; <string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name> (<year>2000</year>). <article-title>Genetic epidemiology of major depression: Review and meta-analysis</article-title>. <source>American Journal of Psychiatry</source>, <volume>157</volume>(<issue>10</issue>), <fpage>1552</fpage>&#x02013;<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.157.10.1552</pub-id><pub-id pub-id-type="pmid">11007705</pub-id>
</mixed-citation></ref><ref id="r61"><mixed-citation publication-type="journal" id="ref61"><string-name><surname>Svedberg</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Johansson</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wallander</surname>, <given-names>M.-A.</given-names></string-name>, &#x00026; <string-name><surname>Pedersen</surname>, <given-names>N. L</given-names></string-name>. (<year>2008</year>). <article-title>No evidence of sex differences in heritability of irritable bowel syndrome in Swedish twins</article-title>. <source>Twin Research and Human Genetics</source>, <volume>11</volume>(<issue>2</issue>), <fpage>197</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1375/twin.11.2.197</pub-id><pub-id pub-id-type="pmid">18361721</pub-id>
</mixed-citation></ref><ref id="r62"><mixed-citation publication-type="journal" id="ref62"><string-name><surname>Talley</surname>, <given-names>N. J.</given-names></string-name>, &#x00026; <string-name><surname>Spiller</surname>, <given-names>R.</given-names></string-name> (<year>2002</year>). <article-title>Irritable bowel syndrome: A little understood organic bowel disease?</article-title>
<source>Lancet (London, England)</source>, <volume>360</volume>(<issue>9332</issue>), <fpage>555</fpage>&#x02013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(02)09712-X</pub-id><pub-id pub-id-type="pmid">12241674</pub-id>
</mixed-citation></ref><ref id="r63"><mixed-citation publication-type="journal" id="ref63"><string-name><surname>Tattan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>&#x000d8;rnb&#x000f8;l</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Wellnitz</surname>, <given-names>K. B.</given-names></string-name>, <string-name><surname>Hanssen</surname>, <given-names>D. J. C.</given-names></string-name>, <string-name><surname>Dantoft</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Rosmalen</surname>, <given-names>J. G. M.</given-names></string-name>, &#x02026; <string-name><surname>Petersen</surname>, <given-names>M. W</given-names></string-name>. (<year>2024</year>). <article-title>Factors associated with having previously received a diagnosis of fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome: A cross sectional DanFunD study</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>181</volume>, <fpage>111693</fpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychores.2024.111693</pub-id><pub-id pub-id-type="pmid">38724318</pub-id>
</mixed-citation></ref><ref id="r64"><mixed-citation publication-type="journal" id="ref64"><string-name><surname>Tavares</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Lopera-Maya</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Bonfiglio</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Sinha</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Marques</surname>, <given-names>F. Z.</given-names></string-name>, &#x02026; <string-name><surname>D&#x02019;Amato</surname>, <given-names>M</given-names></string-name>. (<year>2024</year>). <article-title>Rome III criteria capture higher irritable bowel syndrome SNP-heritability and highlight a novel genetic link with cardiovascular traits</article-title>, <source>Cellular and Molecular Gastroenterology and Hepatology</source>, <volume>18</volume>(<issue>2</issue>), <fpage>101345</fpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2024.04.002</pub-id><pub-id pub-id-type="pmid">38643935</pub-id>
</mixed-citation></ref><ref id="r65"><mixed-citation publication-type="journal" id="ref65"><string-name><surname>Tesfaye</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jaholkowski</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hindley</surname>, <given-names>G. F. L.</given-names></string-name>, <string-name><surname>Shadrin</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Rahman</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Bahrami</surname>, <given-names>S.</given-names></string-name>, &#x02026; <string-name><surname>Andreassen</surname>, <given-names>O. A</given-names></string-name>. (<year>2023</year>). <article-title>Shared genetic architecture between irritable bowel syndrome and psychiatric disorders reveals molecular pathways of the gut-brain axis</article-title>. <source>Genome Medicine</source>, <volume>15</volume>(<issue>1</issue>), <fpage>60</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-023-01212-4</pub-id><pub-id pub-id-type="pmid">37528461</pub-id>
</mixed-citation></ref><ref id="r66"><mixed-citation publication-type="journal" id="ref66"><string-name><surname>Thomas</surname>, <given-names>N. S.</given-names></string-name>, <string-name><surname>Gillespie</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Kendler</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Oldehinkel</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Rosmalen</surname>, <given-names>J. G. M.</given-names></string-name>, &#x00026; <string-name><surname>van Loo</surname>, <given-names>H. M</given-names></string-name>. (<year>2024</year>). <article-title>Comorbidity and sex differences in functional disorders and internalizing disorders</article-title>. <source>General Hospital Psychiatry</source>, <volume>90</volume>, <fpage>91</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.genhosppsych.2024.07.013</pub-id><pub-id pub-id-type="pmid">39079424</pub-id>
</mixed-citation></ref><ref id="r67"><mixed-citation publication-type="journal" id="ref67"><string-name><surname>van der Meulen</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Bos</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bakker</surname>, <given-names>S. J. L.</given-names></string-name>, <string-name><surname>Gans</surname>, <given-names>R. O. B.</given-names></string-name>, &#x00026; <string-name><surname>Rosmalen</surname>, <given-names>J. G. M</given-names></string-name>. (<year>2024</year>). <article-title>Validity and diagnostic overlap of functional somatic syndrome diagnoses</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>181</volume>, <fpage>111673</fpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychores.2024.111673</pub-id><pub-id pub-id-type="pmid">38678828</pub-id>
</mixed-citation></ref><ref id="r68"><mixed-citation publication-type="journal" id="ref68"><string-name><surname>van Loo</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Beijers</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wieling</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>de Jong</surname>, <given-names>T. R.</given-names></string-name>, <string-name><surname>Schoevers</surname>, <given-names>R. A.</given-names></string-name>, &#x00026; <string-name><surname>Kendler</surname>, <given-names>K. S</given-names></string-name>. (<year>2023</year>). <article-title>Prevalence of internalizing disorders, symptoms, and traits across age using advanced nonlinear models</article-title>. <source>Psychological Medicine</source>, <volume>53</volume>(<issue>1</issue>), <fpage>78</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291721001148</pub-id><pub-id pub-id-type="pmid">33849670</pub-id>
</mixed-citation></ref><ref id="r70"><mixed-citation publication-type="journal" id="ref70"><string-name><surname>Wang</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Snieder</surname>, <given-names>H.</given-names></string-name>, &#x00026; <string-name><surname>Hartman</surname>, <given-names>C. A</given-names></string-name>. (<year>2022</year>). <article-title>Familial co-aggregation and shared heritability between depression, anxiety, obesity and substance use</article-title>. <source>Translational Psychiatry</source>, <volume>12</volume>(<issue>1</issue>), <fpage>108</fpage>. <pub-id pub-id-type="doi">10.1038/s41398-022-01868-3</pub-id><pub-id pub-id-type="pmid">35296640</pub-id>
</mixed-citation></ref><ref id="r71"><mixed-citation publication-type="journal" id="ref71"><string-name><surname>Warren</surname>, <given-names>J. W.</given-names></string-name>, &#x00026; <string-name><surname>Clauw</surname>, <given-names>D. J</given-names></string-name>. (<year>2012</year>). <article-title>Functional somatic syndromes: Sensitivities and specificities of self-reports of physician diagnosis</article-title>. <source>Psychosomatic Medicine</source>, <volume>74</volume>(<issue>9</issue>), <fpage>891</fpage>&#x02013;<lpage>895</lpage>. <pub-id pub-id-type="doi">10.1097/PSY.0b013e31827264aa</pub-id><pub-id pub-id-type="pmid">23071343</pub-id>
</mixed-citation></ref><ref id="r72"><mixed-citation publication-type="journal" id="ref72"><string-name><surname>Wolfe</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Clauw</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Fitzcharles</surname>, <given-names>M.-A.</given-names></string-name>, <string-name><surname>Goldenberg</surname>, <given-names>D. L.</given-names></string-name>, <string-name><surname>Katz</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Mease</surname>, <given-names>P.</given-names></string-name>, &#x02026; <string-name><surname>Yunus</surname>, <given-names>M. B</given-names></string-name>. (<year>2010</year>). <article-title>The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity</article-title>. <source>Arthritis Care &#x00026; Research</source>, <volume>62</volume>(<issue>5</issue>), <fpage>600</fpage>&#x02013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1002/acr.20140</pub-id><pub-id pub-id-type="pmid">20461783</pub-id>
</mixed-citation></ref><ref id="r73"><mixed-citation publication-type="journal" id="ref73"><string-name><surname>Wolfe</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Schmukler</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jamal</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Castrejon</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Gibson</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Srinivasan</surname>, <given-names>S.</given-names></string-name>, &#x02026; <string-name><surname>Pincus</surname>, <given-names>T</given-names></string-name>. (<year>2019</year>). <article-title>Diagnosis of fibromyalgia: Disagreement between fibromyalgia criteria and clinician-based fibromyalgia diagnosis in a university clinic</article-title>. <source>Arthritis Care &#x00026; Research</source>, <volume>71</volume>(<issue>3</issue>), <fpage>343</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1002/acr.23731</pub-id><pub-id pub-id-type="pmid">30724039</pub-id>
</mixed-citation></ref><ref id="r74"><mixed-citation publication-type="journal" id="ref74"><string-name><surname>Wray</surname>, <given-names>N. R.</given-names></string-name>, &#x00026; <string-name><surname>Gottesman</surname>, <given-names>I. I</given-names></string-name>. (<year>2012</year>). <article-title>Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder</article-title>. <source>Frontiers in Genetics</source>, <volume>3</volume>, <fpage>118</fpage>. <pub-id pub-id-type="doi">10.3389/fgene.2012.00118</pub-id><pub-id pub-id-type="pmid">22783273</pub-id>
</mixed-citation></ref><ref id="r75"><mixed-citation publication-type="journal" id="ref75"><string-name><surname>Zeileis</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>K&#x000f6;ll</surname>, <given-names>S.</given-names></string-name>, &#x00026; <string-name><surname>Graham</surname>, <given-names>N</given-names></string-name>. (<year>2020</year>). <article-title>Various versatile variances: An object-oriented implementation of clustered covariances in R</article-title>. <source>Journal of Statistical Software</source>, <volume>95</volume>, <fpage>1</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v095.i01</pub-id></mixed-citation></ref></ref-list></back></article>